SCHEMBL7776553

SCHEMBL7776553

OC1C=CC=CC2=C1CCCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7777208 0.98
SCHEMBL6505987 0.73 KDM4E (0.35)
SCHEMBL8770709 0.69
SCHEMBL27712951 0.67
Bromide SCHEMBL8154456 0.65
Hydrochloric Acid SCHEMBL760404 0.65
Hydrochloric Acid SCHEMBL30387660 0.63
SCHEMBL29449375 0.63
SCHEMBL10711200 0.62
SCHEMBL4743792 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102686221-A Method of treating pain TRIGEMINA INC 2012-09-19 CN disclosed
CN-102307895-A Methods and compositions for treating or preventing narcotic withdrawal symptoms UNIV LELAND STANFORD JUNIOR 2012-01-04 CN disclosed
EP-1129072-A2 N-SUBSTITUTED AZACYCLES, THEIR PREPARATION AND THEIR USE AS ORL-1 RECEPTOR LIGANDS Smithkline Beecham S.p.A. (IT) 2001-09-05 EP disclosed
WO-2000027815-A2 N-SUBSTITUTED AZACYCLES, THEIR PREPARATION AND THEIR USE AS ORL-1 RECEPTOR LIGANDS SMITHKLINE BEECHAM SPA (IT) 2000-05-18 WO disclosed